Mast cells-intestinal cancer cells crosstalk is mediated by TNF-alpha and sustained by the IL-33/ST2 axis
Cancer Immunology, Immunotherapy · 2025
DOI: 10.1007/s00262-025-04054-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2025. Verfasst von Chiara Dal Secco und 8 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Section, Department of Medicine, University of Udine, Udine, Italy. Hauptthemen laut MEDLINE: Mast Cells, Interleukin-33, Interleukin-1 Receptor-Like 1 Protein, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Udine, Fondazione AIRC per la ricerca sul cancro ETS, Ministero dell'Università e della Ricerca.
Abstract (Originalsprache)
It is common knowledge that mast cells (MCs) exert different roles in the gastrointestinal tract, from the maintenance of homeostasis to the onset and propagation of different gut diseases such as food allergies, infections, inflammation, and cancer. However, the mechanisms through which MCs dialog and influence the intestinal tissue are not completely known. To get insight into the bidirectional crosstalk between MCs and the intestinal microenvironment, both in homeostatic and pathological settings, colon organoids from intestinal epithelium of healthy mice and adenomas from AOM/DSS-treated mice have been exploited and co-cultured with MCs. The influence of MCs on organoid architecture and the effect of healthy and tumoral organoids on the phenotype and responsiveness of MCs have been addressed. We observed that MCs interact with intestinal organoids and contribute to the differentiation of healthy organoids by upregulating the expression of mucin-2, chromogranin A, cadherin-1, and claudin 4. On the contrary, in co-culture with tumoral organoids a decrease in cell proliferation, chromogranin A, and lysozyme expression was observed. Tumoral organoids have been shown to activate MCs via the IL-33/ST2 axis leading to increased release of TNF-α which in turn was responsible for the observed effects on tumoral organoids. Our results indicate that MCs are important mediators of intestinal tissue homeostasis and that a different environment can shape and direct MCs toward the dampening or propagation of the inflammatory response. Ultimately, our MC-organoid co-cultures represent a valid in vitro tool to investigate the role of MCs in the gut.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunology Section, Department of Medicine, University of Udine, Udine, Italy.
- Molecular Biology Section, Department of Medicine, University of Udine, Udine, Italy.
- Immunology Section, Department of Medicine, University of Udine, Udine, Italy. carlo.pucillo@uniud.it.
Förderung
- Università degli Studi di Udine
- Fondazione AIRC per la ricerca sul cancro ETS
- Ministero dell'Università e della Ricerca
Zitieren
APA
Dal Secco, C., Tonon, S., Trevisan, C., Martinis, E., Valeri, V., Codrich, M., Tell, G., Frossi, B., & Pucillo, C. E. M. (2025). Mast cells-intestinal cancer cells crosstalk is mediated by TNF-alpha and sustained by the IL-33/ST2 axis. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-025-04054-8
Vancouver
Dal Secco C, Tonon S, Trevisan C, Martinis E, Valeri V, Codrich M, et al. Mast cells-intestinal cancer cells crosstalk is mediated by TNF-alpha and sustained by the IL-33/ST2 axis. Cancer Immunology, Immunotherapy. 2025. doi:10.1007/s00262-025-04054-8
BibTeX
@article{DalSecco2025,
author = {Dal Secco, Chiara and Tonon, Silvia and Trevisan, Caterina and Martinis, Eleonora and Valeri, Viviana and Codrich, Marta and Tell, Gianluca and Frossi, Barbara and Pucillo, Carlo E M},
title = {Mast cells-intestinal cancer cells crosstalk is mediated by TNF-alpha and sustained by the IL-33/ST2 axis},
journal = {Cancer Immunology, Immunotherapy},
year = {2025},
doi = {10.1007/s00262-025-04054-8}
}
EUVIMED